Navidea Biopharmaceuticals, Inc. NAVBQ
Set alert
0.00 USD 0.00 0.00%
At close · Oct 30
0.0001 Day range 0.0001
0.0001 52-week range 0.0431
- YTD
- 0.00%
- 1 year
- 0.00%
- Open
- 0.0001
- Prev close
- 0.0001
- Mkt cap
- 10.01K
- Vol
- 162.03K
- Avg vol
- 7.99K
- EPS
- -0.05
- P/E
- 0.00
More statistics
- Low
- 0.0001
- High
- 0.0001
2Y chart
Signals (67)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 13, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 9, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 9, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 5, 2026 | 3 weeks ago |
| RSI: Overbought | Oct 5, 2026 | 3 weeks ago |
| MACD: Buy Signal | Aug 11, 2026 | 2 months ago |
| SMA: Bearish | Jul 17, 2026 | 3 months ago |
| SMA: Bearish | Jul 17, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 9, 2026 | 3 months ago |
| SMA: Bullish | Jul 8, 2026 | 3 months ago |
| SMA: Bullish | Jul 8, 2026 | 3 months ago |
| SMA: Bearish | Jul 2, 2026 | 4 months ago |
| SMA: Bearish | Jul 2, 2026 | 4 months ago |
| SMA: Bullish | Jul 1, 2026 | 4 months ago |
| SMA: Bullish | Jul 1, 2026 | 4 months ago |
| MACD: Buy Signal | Jul 1, 2026 | 4 months ago |
| RSI: Overbought | Jul 1, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 16, 2026 | 4 months ago |
| SMA: Bearish | Jun 11, 2026 | 4 months ago |
| SMA: Bearish | Jun 11, 2026 | 4 months ago |
| SMA: Bullish | Jun 10, 2026 | 4 months ago |
| RSI: Overbought | Jun 10, 2026 | 4 months ago |
| MACD: Buy Signal | Jan 26, 2026 | 9 months ago |
| SMA: Bearish | Dec 29, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 29, 2025 | 10 months ago |
| SMA: Bullish | Dec 26, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 26, 2025 | 10 months ago |
| SMA: Bearish | Dec 24, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 24, 2025 | 10 months ago |
| SMA: Bullish | Dec 23, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 23, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 19, 2025 | 10 months ago |
| SMA: Bearish | Dec 16, 2025 | 10 months ago |
| SMA: Bearish | Dec 16, 2025 | 10 months ago |
| SMA: Bullish | Dec 15, 2025 | 10 months ago |
| RSI: Overbought | Dec 15, 2025 | 10 months ago |
| MACD: Buy Signal | Oct 7, 2025 | 1 year ago |
| RSI: Oversold | Sep 30, 2025 | 1 year ago |
| SMA: Bearish | Sep 16, 2025 | 1 year ago |
| RSI: Oversold | Sep 16, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 9, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 22, 2025 | 1 year ago |
| SMA: Bullish | Aug 20, 2025 | 1 year ago |
| SMA: Bearish | Aug 19, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 19, 2025 | 1 year ago |
| SMA: Bullish | Jul 28, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 30, 2025 | 1 year ago |
| MACD: Sell Signal | May 19, 2025 | 1 year ago |
| SMA: Bearish | May 15, 2025 | 1 year ago |
| RSI: Overbought | May 12, 2025 | 1 year ago |
| MACD: Buy Signal | May 2, 2025 | 1 year ago |
| SMA: Bullish | Apr 30, 2025 | 1 year ago |
| SMA: Bearish | Apr 24, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 24, 2025 | 1 year ago |
| RSI: Oversold | Apr 24, 2025 | 1 year ago |
| SMA: Bullish | Mar 26, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 24, 2025 | 1 year ago |
| SMA: Bearish | Mar 3, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 3, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 11, 2025 | 1 year ago |
| SMA: Bullish | Feb 10, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 10, 2025 | 1 year ago |
| SMA: Bearish | Feb 5, 2025 | 1 year ago |
| SMA: Bullish | Jan 31, 2025 | 1 year ago |
| RSI: Overbought | Jan 31, 2025 | 1 year ago |
| MACD: Buy Signal | Dec 20, 2024 | 1 year ago |
| RSI: Oversold | Nov 29, 2024 | 1 year ago |
News
- Navidea Biopharmaceuticals, Inc. Files for Bankruptcy
- Navidea Biopharmaceuticals, Inc. Announces Extension of Authority to Implement a Reverse Stock Split
- Navidea Biopharmaceuticals Announces the Extension of Plan Designed to Protect NOLs and Other Tax Assets
- Navidea Biopharmaceuticals, Inc. Announces Results of Exploratory Analysis Completed on July 2, 2024
- Navidea Biopharmaceuticals, Inc. announces special meeting of stockholders to be held July 8, 2024
- Navidea Biopharmaceuticals, Inc. Files Form 15 to Voluntarily Deregister and Suspend its SEC Reporting Obligations
- Navidea Biopharmaceuticals, Inc. and Capital Royalty Partners II, L.P. Enter Binding Settlement Agreement and Mutual Release
- Navidea Biopharmaceuticals, Inc. Announces NYSE American's Decision to Suspend Trading In Its Common Stock
- NYSE American to Suspend Trading in Navidea Biopharmaceuticals, Inc. (NAVB)
- Navidea Biopharmaceuticals, Inc. NAVB Requests Oral Hearing With NYSE Hearing Panel
Your note
Sign in to keep a note on NAVBQ — it syncs with the Stock Master app.